Immunovative Therapies, Novo Energies deal

In December, Immunovative granted Novo Energies an exclusive, worldwide license to commercialize all products covered under Immunovative's patents or patent applications. Immunovative, which has rights to the IP from the University of Arizona, will receive $450,000 up front plus

Read the full 391 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE